Print

Abbott Laboratories (ABT)' Kaletra HIV-Drug Patent Rejected in India, Allowing Cipla Ltd. Copies  
1/4/2011 6:46:31 AM

Bloomberg -- Abbott Laboratories was refused copyright protection on its AIDS drug Kaletra by India’s patent office, allowing Cipla Ltd. and other generic-drug companies to continue selling copies.
//-->